Allan G. Beniashvily

Safety and efficacy of aviandr in patients with generalized anxiety disorder: A multicenter, randomized, double-blind, placebo-controlled, dose-finding, pilot study.

O. Bukhanovskaya, A. Ivashchenko, R. Karapetian, 2021, Journal of psychiatric research.

Add-on clinical effects of selective antagonist of 5HT6 receptors AVN-211 (CD-008-0173) in patients with schizophrenia stabilized on antipsychotic treatment: pilot study

M. Morozova, Y. Lavrovsky, A. Ivachtchenko, 2013, CNS Spectrums.